<DOC>
	<DOCNO>NCT02315833</DOCNO>
	<brief_summary>The purpose study validate novel hypothesis daily use L-cysteine ( AcetiumÂ® capsule ) effective mean decrease frequency ( completely abort ) headache attack migraine patient .</brief_summary>
	<brief_title>The Efficacy L-cysteine Prevention Headache Attacks Migraine Patients</brief_title>
	<detailed_description />
	<mesh_term>Headache</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>1865 year male/female subject report migraine attack frequency 28 time per month , less 15 migraine day ( NMD ) per month . To calculated separate attack , least 48h freedom headache two attack migraine . migraine without aura present least 1 year prior enter study subject enrol report onset migraine 50 year age patient meet International Classification Headache Disorders II criterion medication overuse patient take antipsychotic antidepressant medication previous 3 month patient abuse alcohol drug patient resistant acute migraine drug optimally prescribe potentially fertile sexually active woman practise contraception acute chronic pain disorder severe psychiatric disease infection malignancy short life expectancy cardiovascular disease cerebrovascular disease uncontrolled hypertension degenerative central nervous system diseases pregnant lactate woman regular user Acetium capsule indication person suffer renal dysfunction cystinuria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Aura</keyword>
</DOC>